Creative One Wealth, LLC Gossamer Bio, Inc. Transaction History

Creative One Wealth, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	SELL	$0.78 - $1.82 $2,899 - $6,764	-3,717 Reduced 11.81%	27,750 $23,000
Q2 2023 Aug 16, 2023	SELL	$0.98 - $1.53 $1,694 - $2,645	-1,729 Reduced 5.21%	31,467 $38,000
Q2 2023 Aug 14, 2023	BUY	$0.98 - $1.53 $1,588 - $2,480	1,621 Added 5.13%	33,196 $276,000
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $2,472 - $7,521	2,576 Added 8.88%	31,575 $40,000
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $4,233 - $31,312	2,433 Added 9.16%	28,999 $63,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $48,501 - $100,097	-6,727 Reduced 20.21%	26,566 $318,000
Q2 2022 Aug 12, 2022	SELL	$5.97 - $9.97 $4,465 - $7,457	-748 Reduced 2.2%	33,293 $279,000
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $5,190 - $7,681	615 Added 1.84%	34,041 $295,000
Q4 2021 Feb 15, 2022	BUY	$10.12 - $14.07 $16,465 - $22,891	1,627 Added 5.12%	33,426 $378,000
Q3 2021 Nov 16, 2021	BUY	$7.25 - $13.23 $81,874 - $149,406	11,293 Added 55.07%	31,799 $400,000
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $43,256 - $52,718	5,407 Added 35.81%	20,506 $167,000
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $130,304 - $165,183	15,099 New	15,099 $140,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Creative One Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Creative One Wealth, LLC with notifications on news.